Hence, MINERVA was suggested to act as an upstream regulator of Nrf2-mediated response to oxidative stress in cancer by hindering interaction of Keap1 and Nrf2 by competing for the Kelch domain through the “DLGXnETGE” motif [12]. The gene discussed is NFE2L2; the disease is cancer.